Leo Pranitis, Prisyna’s GM interviewed by Dr. Howard Farran of DentalTown

CLAREMONT, Calif. – November 6, 2019 – Recently, Prisyna’s General Manager Leo Pranitis was interviewed by Dr. Howard Farran of DentalTown. Leo discusses how he is leveraging his 25-year career in the oral healthcare arena to now successfully commercialize Moisyn, Synedent, and Synedent FLX.

About Prisyna 

Prisyna, the oral healthcare division of Synedgen, is developing and commercializing a new class of oral health care products based on glycomics, a revolutionary approach using natural glycopolymers to target the mucosal interface. Prisyna uses this unique technology to develop oral health care products that clean the mouth, reduce pain and irritation on sensitive mucosal surfaces and improve overall oral health. Prisyna is building a family of environmentally safe products using cutting edge science to promote healthy teeth, gums and oral surfaces. http://www.prisyna.com/

Media Contact: 

Leo Pranitis General Manager, Prisyna 909.477.6858 leo.pranitis@prisyna.com

Prisyna’s GM, Leo Pranitis talks about ChitoTek

CLAREMONT, Calif. – October 17, 2019 – Prisyna’s General Manager, Leo Pranitis, talks about why the innovative ChitoTek™ molecule that is found in Moisyn® Dry Mouth and Synedent® Mouthwash is so effective. Prisyna is leveraging the science that continues to be proven out in the medical arena through its parent company, Synedgen.

 

About Prisyna 

Prisyna, the oral healthcare division of Synedgen, is developing and commercializing a new class of oral health care products based on glycomics, a revolutionary approach using natural glycopolymers to target the mucosal interface. Prisyna uses this unique technology to develop oral health care products that clean the mouth, reduce pain and irritation on sensitive mucosal surfaces and improve overall oral health. Prisyna is building a family of environmentally safe products using cutting edge science to promote healthy teeth, gums and oral surfaces. http://www.prisyna.com/

Media Contact: 

Leo Pranitis General Manager, Prisyna 909.477.6858 leo.pranitis@prisyna.com

Leo Pranitis, GM of Prisyna discusses Moisyn for dry mouth relief with Amber Auger, MPH, RDH

CLAREMONT, Calif. – September 13, 2019 – Leo Pranitis, General Manager of Prisyna Oral Healthcare, spoke with Amber Auger, MPH, RDH, during the RDH Under One Roof Annual Meeting on August 2, 2019 in Dallas, Tx. They discussed Prisyna’s unique and patented molecule, ChitoTek, and how that innovation is providing greater options for patients and practitioners alike. 

About Prisyna 

Prisyna, the oral healthcare division of Synedgen, is developing and commercializing a new class of oral health care products based on glycomics, a revolutionary approach using natural glycopolymers to target the mucosal interface. Prisyna uses this unique technology to develop oral health care products that clean the mouth, reduce pain and irritation on sensitive mucosal surfaces and improve overall oral health. Prisyna is building a family of environmentally safe products using cutting edge science to promote healthy teeth, gums and oral surfaces. http://www.prisyna.com/

Media Contact: 

Leo Pranitis General Manager, Prisyna 909.477.6858 leo.pranitis@prisyna.com

Synedgen’s Glycopolymer Technology Licensed to Synspira Therapeutics Demonstrates Improvement in Abnormal Cystic Fibrosis Mucus and Pulmonary Disease

Synspira Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with cystic fibrosis and other rare diseases, today announced the results of a publication exploring the efficacy of SNSP113 as a potential treatment for improving lung function in people with cystic fibrosis. The publication, “A glycopolymer improves viscoelasticity and mucociliary transport of abnormal cystic fibrosis mucus” was published in the April issue of The Journal of Clinical Investigation and evaluated a number of mechanisms where SNSP113 could impact abnormal mucus structure and improve mucus clearance.

Prisyna Launches New Website

-Online presence showcases Prisyna’s innovative science through impactful branding and greater online resources for both professionals and consumers –

CLAREMONT, Calif. – January 23, 2019 – Prisyna, the oral care division of Synedgen, founded to optimize oral health using advanced, proprietary glycomics technology, announced that they have launched a completely new website for 2019. 

“It’s exciting to finally bring alive this beautiful and informative website that effectively showcases the innovative science we offer for oral healthcare practitioners and consumers alike,” said Leo Pranitis, General Manager of Prisyna. “Visitors to our site can expect to see a comprehensive set of resources on oral health, as well as gain a much greater understanding of how our products are addressing that challenge.” 

The new website is designed to create a greater connection to the audience, through testimonials and other proof source, noted Mr. Pranitis. 

“From the home page throughout, visitors will see the level of importance we place on the individual who is looking for a safer and more effective option to improve their oral health. Additionally, the ability to easily view our various product configurations and see the full ingredient list is something I believe will greatly enhance our current customers’ experience as well as provide a welcoming and informative environment for new visitors to the site.” 

Prisyna’s new website can be found at https://www.prisyna.com.

About Prisyna 

Prisyna, the oral healthcare division of Synedgen, is developing and commercializing a new class of oral health care products based on glycomics, a revolutionary approach using natural glycopolymers to target the mucosal interface. Prisyna uses this unique technology to develop oral health care products that clean the mouth, reduce pain and irritation on sensitive mucosal surfaces and improve overall oral health. Prisyna is building a family of environmentally safe products using cutting edge science to promote healthy teeth, gums and oral surfaces. http://www.prisyna.com/ 

Media Contact: 

Leo Pranitis
General Manager, Prisyna 909.477.6858 leo.pranitis@prisyna.com

Synedgen showcased in the Top 10 Cystic Fibrosis Stories of 2018 by CF News Today

Studies led by Synedgen and Keck Graduate Institute show Ion-Sugar Interaction in Airway Mucus Has Implications for CF. This research addresses ion interactions in different kinds of cell surfaces and water-containing gels. Understanding how each type of ion affects the structure, electrical potential, and fluid behavior of the airway-surface layers in the lung has direct implications for designing drug targets that influence pulmonary behavior. Read on Cystic Fibrosis News Today

Synedgen Welcomes Student Interns

Synedgen is pleased to welcome 3 student interns for the summer.

Allyson Leicht is a Senior dual major in Chemistry and Economics at Grinnell College, Iowa. At Grinnell she has worked on several research projects including a computational chemistry project to examine the mechanisms of hydrogen and deuterium exchange of arginine containing peptides, and a synthesis project to generate and analyze Ircinin produced from economically priced ingredients. Outside of the laboratory she has run a textbook lending library, worked as a peer tutor, worked at a preschool, and served as Project Manager for Grinnell’s “Alternative Breaks Program”, a student-run organization that offers students the opportunity to travel as members of a fun, safe, and intentional service community during breaks.

At Synedgen, Allyson is working on synthesizing new compounds to help expand Synedgen’s molecular library, including independent synthesis of at minimum one compound, generation of synthesis precursors through alternative synthesis pathways, and characterization of new compounds by FTIR, 1D and 2D NMR, and size exclusion chromatography.

Alyssa Thompson is a third year student at the University of Cincinnati (UC) majoring in Middle Childhood Education with a focus in science and English content areas. After graduating from the University of Cincinnati, she hopes to teach biology while pursuing her Masters of Science in Education, and eventually her PhD in Education. Her ultimate goal is to work in a STEM education department, preparing future science teachers to better teach, excite, and encourage students in the classroom.

Briana Thomas is a rising Junior at the University of Cincinnati majoring in Biological Sciences. During the academic year, she works in a research lab at UC. After completing her degree, she plans to attend medical school for a MD/PhD in Pediatrics with an interest in Neurology. Her hopes are to not only provide the best care to each patient she will eventually treat, but also to make healthcare more accessible to low-income families.

This summer the UC students are interning in the research and development department at Synedgen. They experience hands-on training and active research in the fields of microbiology and cell biology. Their research will aid in the characterization and evaluation of promising new molecules. These new molecules, developed through Synedgen’s glycomic technology platform, will be assessed for their impact on infection, healing and inflammation.

“Our goal is to give the interns hands-on research experience that can’t be learned in a classroom and expose them to real life laboratory challenges,” said Synedgen president Shenda Baker PhD. “The study of our novel molecules gives the students a unique opportunity to perform interdisciplinary research in an emerging field.”

Briana Thomas, Alyssa Thompson, Allyson Leicht